Navigation Links
Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
Date:9/17/2007

ine to provide cross-protection to variants of the H5N1 strains is ongoing.

Sanofi pasteur has committed, in the event of a pandemic being declared by the World Health Organization (WHO), to producing the largest possible number of doses of its most advanced pandemic influenza vaccine in the shortest possible time. In order to increase its capacity, sanofi pasteur initiated clinical trials with a novel adjuvant aimed at dramatically reducing the amount of antigen needed to elicit a protective immune response to the H5N1 strain currently identified by global health authorities and experts as a potential source for the next pandemic.

According to the WHO, the next influenza pandemic could result in 1 million to 2.3 million hospitalizations and 280,000 to 650,000 deaths in industrialized nations alone. Its impact is expected to be even more devastating in developing countries.

With production of 170 million doses of influenza vaccine in 2006, sanofi pasteur confirmed its leadership as the world's largest manufacturer of seasonal influenza vaccine, supplying a large portion of the estimated global production of about 350 million doses(1). Sanofi pasteur's Vaxigrip(R) and Fluzone(R) influenza virus vaccines are licensed in over 100 countries.

Pandemic Influenza Overview

Influenza is a disease caused by a highly infectious virus that spreads easily from person to person, primarily when an infected individual coughs or sneezes. An influenza pandemic is a global epidemic of an especially virulent virus, newly infectious for humans, and for which there is no preexisting immunity. This is why pandemic strains have such potential to cause severe morbidity and mortality. In an attempt to minimize the impact of a pandemic, many countries are developing national and transnational plans against a possible influenza pandemic situation.

Sanofi Pasteur and Pandemic Preparedness

Sanofi pasteur is committed to global pandemic preparedness. As t
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. New Mexico firm to make flu vaccine at Wisconsin BioManufacturing facility
2. Studies Offer New Insight into HIV Vaccine Development
3. Inacom Information Systems achieves Cisco Systems Partner -Gold Certified status
4. Third Wave Achieves Milestone, Delivers 200,000 SNP Assays to RIKEN In Japan
5. Immune boosting beverage relying on Milwaukee firms packaging technology
6. UW scientist wins Pew grant to study little-known immune cells
7. Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system
8. FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses
9. IT critical in pandemic response, but many are not paying attention
10. Quick response manufacturing and biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 /PRNewswire/ -- ... life sciences industry and an active venture capital ... Indiana State Teachers Retirement Fund, Indiana University, Purdue ... Fairbanks Foundation, and Credit Suisse today announced the ... venture capital fund of funds. ,, Organized through ...
(Date:12/16/2009)... Sequenom, Inc. (Nasdaq: SQNM ), today announced ... David Pendarvis to its board of directors. ... F. Buechler, Ph.D., was president, chief scientific officer ... 1994, Dr. Buechler was Biosite,s director of chemistry. ... senior research scientist for the diagnostics research and ...
(Date:12/16/2009)... Eppendorf has initiated an,import ban ... systems for,infringement of European patent EP 1 ... and/or the quantification of a target compound". ... of the respective products into any country ... to confiscate any,violating products. , ...
(Date:12/15/2009)... 15 Epeius Biotechnologies Corporation, an emerging ... gained international validation of the cutting-edge science behind ... scientists around the world rediscovered the Cyclin ... of cancer pathogenesis and disease progression, and thus ... at the NIH National Cancer Institute investigating the ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... 21 LeMaitre Vascular,Inc. (Nasdaq: LMAT ), ... acquired Biomateriali S.r.l., a privately held Italian,vascular graft ... assumption,of euro 0.8 million in intercompany liabilities, and ... The acquisition was structured as a stock,purchase., ...
... be Only Once-Yearly Implant for Prostate Cancer in ... Indevus Reaffirms Commitment to Prostate Cancer Patients, ... (Nasdaq: IDEV ) today commented on the ... their product,Viadur(R) (leuprolide acetate implant), which is indicated ...
... Memory,Pharmaceuticals Corp. (Nasdaq: MEMY ) today ... double-blind, placebo-controlled Phase 2a clinical,trial of MEM 3454, ... cognitive impairment associated with schizophrenia (CIAS). The,trial is ... effects,of three doses of MEM 3454 in patients ...
Other Biology Technology:LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer 2LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer 3Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R) 2Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R) 3Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia 2Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia 3Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia 4
(Date:12/16/2009)... N.J., Dec. 9 BIO-key International, ... in finger-based biometric identification solutions, today announced ... most respected security publications, named BIO-key International ... the Access Control sub-category Biometrics. ,, (Logo: ... Peter Stephenson, technology editor, SC Magazine, "Biometric ...
(Date:12/16/2009)... 16 European Union (EU) member ... borders, which are increasingly subjected to unauthorised ... in advanced technology security and IT-based systems ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, New analysis ... Border Security Market Assessment - European ...
(Date:12/15/2009)... As soon as babies are born, they are susceptible ... For up to a month, their immune systems aren,t ... often minor, they can lead to serious problems if ... of Missouri researchers have pinpointed a group of depleted ... vaccine. , "We,re trying to improve the immune system ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 2Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 3Researchers work on vaccine to improve immune system in newborns 2Researchers identify new brain pathway for regulating weight and bone mass 10065 1Researchers identify new brain pathway for regulating weight and bone mass 10065 2Cambridge Healthtech Institute and Bio IT World Launch a New eNewsletter 3A Pharma Services News 58168 1Cambridge Healthtech Institute and Bio IT World Launch a New eNewsletter 3A Pharma Services News 58168 25th Annual Stem Cell Summit Set for Feb 16 in New York City 58163 15th Annual Stem Cell Summit Set for Feb 16 in New York City 58163 25th Annual Stem Cell Summit Set for Feb 16 in New York City 58163 3
... a type of blue-green algae known as Nostoc, shows promise ... other neurodegenerative diseases, according to an in vitro study by ... time that a potent agent against Alzheimer's has been isolated ... published in the Dec. 26 issue of the Journal ...
... been used to track the source of illegal drugs, ... some new uses: detecting rapidly growing cancers and studying ... "stable isotope ratio mass spectrometry," can determine where a ... of an element in the substance ?such as the ...
... Institute for Biomedical Research have successfully demonstrated that ... is indeed possible, at least in mice. ... (ANT), proposes that researchers first create genetically altered ... uterus, and then extract stem cells from these ...
Other Biology News:Natural compound from 'pond scum' shows potential activity against Alzheimer's 2War on terror meets war on cancer 2War on terror meets war on cancer 3War on terror meets war on cancer 4War on terror meets war on cancer 5War on terror meets war on cancer 6Researchers offer proof-of-concept for Altered Nuclear Transfer 2Researchers offer proof-of-concept for Altered Nuclear Transfer 3
... monoclonal [6331] to Salmonella typhimurium The genus ... The genus is composed of Gram-negative bacilli that ... major antigens; the "H" or flagellar antigen (phase ... (part of the LPS moiety) and the "Vi" ...
... system from Molecular Devices provides precise dispensing ... The system handles a variety of plate ... and 1536-welland is the first to handle ... optimized to dispense from four different channels ...
... With 36 mg/L sodium pyruvate, 50 mg/L ... mg/L glucose, calcium chloride, and magnesium chloride. ... (BSS) in tissue culture is generally attributed ... 1885, Sydney Ringer developed a solution of ...
This free-standing laminar flow hood provides a horizontal flow of HEPA-filtered air to create a clean processing area. Air return slots along the front and side edges of the work area enhance system...
Biology Products: